Summary
Cholinergic inhibition of myocardial adenylate cyclase activity in cell-free fractions has been known for many years, although the reported degrees of inhibition have been rather modest (20–30%), notably in rat heart fractions. The present study conducted with rat heart subcellular fractions document following major findings: (1) Myocardial adenylate cyclase activity and notably its cholinergic inhibition in cell-free fractions are notoriously labile to storage at 4°C whereas its stimulation by beta adrenergic receptor agonists or forskolin are reasonably well preserved during storage. (2) Among four buffers (Tris, glycylglycine, imidazole and sodium phosphate) examined, sodium phosphate buffer afforded the best preservation of cholinergic inhibitory response of adenylate cyclase. (3) The commonly used biochemical buffers, notably imidazole, exerted deleterious effect on the cholinergic inhibition of myocardial adenylate cyclase such that it was considerably attenuated or barely detectable; this explains, in part, the reported poor inhibition of myocardial enzyme by others. (4) Imidazole buffer, on the other hand, augmented beta adrenergic and forskolin stimulated adenylate cyclase activity. The likely significance of these findings is discussed from consideration that the observed differential influence of buffers results from differential actions on the interactions between the components (receptor/coupling G proteins/catalyst) comprising autonomic receptor coupled adenylate cyclase system in rat heart.
Similar content being viewed by others
References
Watanabe AM: Cholinergic antagonists. In: MR Rosen and BF Hoffman (eds) Cardiac Therapy. Martinus Nijhoff Publishers, Boston, 1983, pp 95–144
Loffelholz K, Pappano AJ: The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37: 1–24, 1985
Sulakhe PV, Jagadeesh G, Braun AP: Cardiac Autonomic Receptors and Adenylate Cyclase in Health and Disease. In: H. Rupp (ed) The Regulation Of Heart Function. George Thieme Verlag, Stuttgart, 1986, pp 71–94
Sulakhe PV, MacKay JE, Rokosh DG, Morris T, Phan TD: Parasympathetic control of the heart: Subcellular mechanisms. In: NS Dhalla, GN Pierce and RE Beamish (eds) Heart Function and Metabolism. Martinus Nijhoff Publishing, Boston, 1987, pp 135–162
St. Louis PJ, Sulakhe PV: Adenylate cyclase, guanylate cyclase and cyclic nucleotide phosphodiesterases in guinea pig cardiac sarcolemma. Biochem J 158: 535–541, 1976
Narayanan N, Sulakhe PV: 5′-Guanylylimidodiphosphate-activated adenylate cyclase of cardiac sarcolemma displays higher affinity for magnesium ions. Mol Pharmacol 13: 1033–1047, 1977
Sulakhe PV, Narayanan N: Differential effects of non-ionic detergents on microsomal and sarcolemmal adenylate cyclase in cardiac muscle. Biochem J 175: 171–180, 1978
Watanabe AM, McConnaughey MM, Strawbridge RA, Fleming JW, Jones LR, Besch HR: Muscarinic cholinergic receptor modulation of beta adrenergic receptor affinity for catecholamines. J Biol Chem 253: 4833–4836, 1978
Jakobs KH, Aktories K, Schultz G: GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists. Naunyn-Schmiedeberg's Arch Pharmacol 310: 113–119, 1979
Jagadeesh G, Sulakhe PV: Gallamine binding to heart M2 cholinergic receptors does not antagonize cholinergic inhibition of adenylate cyclase in isolated plasma membrane. Eur J Pharmacol 109: 311–313, 1985
Fleming JW, Strawbridge RA, Watanabe AM: Muscarinic receptor regulation of adenylate cyclase activity. J Mol Cell Cardiol 19: 47–61, 1987
Gilman AG: G proteins: Transducers of receptor generated signals. Annu Rev Biochem 56: 615–649, 1987
Casey PJ, Gilman AG: G protein involvement in receptoreffector coupling. J Biol Chem 263: 2577–2580, 1988
Hulme EC, Berrie CP, Birdsall NMJ, Burgen ASV: Interactions of muscarinic receptors with guanine nucleotides and adenylate cyclase. In: NJM Birdsall (ed) Drug receptors and their effectors, MacMillan, London, 1980, pp 23–34
Harden TK, Scheer AG, Smith MM: Differential modification of the interaction of cardiac muscarinic and betaadrenergic receptors with a guanine nucleotide binding component(s). Mol Pharmacol 21: 570–580, 1982
Kurose H, Ui M: Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin. J Cyclic Nucleotide Protein Phosphor Res 9: 305–318, 1983
Sulakhe PV, Phan NT, Jagadeesh G: Comparison of cholinergic inhibition and beta adrenergic stimulation of adenylate cyclase from rat and guinea pig hearts: Effects of guanine nucleotide and monovalent cations. Gen Pharmacol 16: 311–320, 1985
Smith MM, Harden TK: Muscarinic cholinergic receptormediated attenuation of adenylate cyclase activity in rat heart membranes. J Cyclic Nucleotide Protein Phosphor Res 10: 197–210, 1985
Braun AP, Sulakhe PV: Muscarinic Cholinergic Receptors. In: AA Boulton, GB Baker and PD Hrdina (eds) Neuromethods. 4 Receptor Binding, Humana Press, N.J., 1986, pp 139–170
Narayanan N, Wei JW, Sulakhe PV: Differences in the cation sensitivity of adenylate cyclase from heart and skeletal muscle: Modification by guanyl nucleotides and isoproterenol. Arch Biochem Biophys 197: 18–29, 1979
Drummond GI, Duncan L: Adenylate cyclase in cardiac tissue. J Biol Chem 245: 976–984, 1970
Seamon KB, Daly JW: Activation of cyclic AMP-generating system in brain membranes and slices by the diterpene forskolin: augmentation of receptor-mediated responses. J Neurochem 38: 532–544, 1982
Birnbaumer L, Codina J, Mattera R, Cerione RA, Hildebrandt JD, Sunyer T, Rojas FJ, Caron MG, Lefkowitz RJ, Iyengar R: Regulation of hormone receptors and adenylyl cyclases by guanine nucleotide binding N proteins. Recent Prog Hor Res 41: 41–99, 1985
Malbon CC, Mangano TJ, Watkins DC: Heart contains two substrates (Mr = 40,000 and 41,000) for pertussis toxincatalyzed ADP-ribosylation that co-purify with Ns. Biochem Biophys Res Commun 128: 809–815, 1985
Liang BT, Galper JB: Differential sensitivity of alpha, and alpha; to ADP-ribosylation by pertussis toxin in the intact cultured embryonic chick ventricular myocyte: Relationship to the roles of G proteins in the coupling of muscarinic receptors to inhibition of adenylate cyclase activity. Biochem Pharmacol 37: 4549–4555, 1988
Jacobsson BA, Bergh CH, Hjalmarson A: Corticosteroid modulation of muscarinic receptors in rat myocardial membranes. Biochim Biophys Acta 760: 77–83, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jagadeesh, G., Gupta, R.C. & Sulakhe, P.V. Muscarinic cholinergic receptor mediated inhibitory transduction of adenylate cyclase activity in subcellular fractions from rat heart: improved detection in sodium phosphate buffer. Mol Cell Biochem 93, 35–45 (1990). https://doi.org/10.1007/BF00223490
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00223490